Wednesday, September 23, 2020

Logo Central America Link

Colombia to force Novartis to lower drug prices

Friday, June 10, 2016


Colombia’s government will unilaterally force the world’s largest drugmaker Novartis to lower prices of a popular leukemia medicine in a closely followed patent dispute.

Health Minister Alejandro Gaviria told reporters that two weeks of negotiations with the Swiss company had ended without an agreement. As a result, he’s following through on a threat to declare the drug Gleevec in the public interest, the first step in breaking Novartis’ monopoly in Colombia.


Source: Associated Press